TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35674507

Group type: EXPERIMENTAL
Intervention: High-dose quadrivalent influenza vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-dose quadrivalent influenza vaccine
Number of subjects: 0
Study: 32345132

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 12 weeks, 3 days/week, 10 repetitions at 70% 1RM
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 44
Study: 33152329

Group type: EXPERIMENTAL
Intervention: Three-field lymphadenectomy (3-FL)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Two-field lymphadenectomy (2-FL)
Number of subjects: 76
Study: 32879630

Group type: EXPERIMENTAL
Intervention: Households advocating latrine IEC by Health Extension Workers (HEWs)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Households living in their private house
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Households with government employees
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Households with latrines made on slab floor
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Households with latrines constructed inside the household compound
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Households receiving latrine IEC by Women Development Armies (WDAs)
Number of subjects: 756
Study: 35413856

Group type: EXPERIMENTAL
Intervention: Unilateral training of the ipsilesional arm using Virtual Reality and Manipulation Training (VRMT) protocol, 3 one-hour sessions per week for 5 weeks.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional intervention on the contralesional arm, 3 one-hour sessions per week for 5 weeks.
Number of subjects: 120
Study: 33887147

Group type: EXPERIMENTAL
Intervention: Decrease of 0.1 mmol/L serum calcium
Number of subjects: 76226
Study: 35444642

Group type: COMPARATOR
Intervention: Standard therapy (ST) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All arms combined
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall CD19+CD20+ B cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD19+CD20+CD27+ memory B cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-dsDNA levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complement levels
Number of subjects: 0
Study: 34453262

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.025% formulation 5
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.025% formulation 13
Number of subjects: 88

Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% cream (Control)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 88
Study: 35758344

Group type: EXPERIMENTAL
Intervention: Rational emotive family health therapy (12-session treatment programme)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 88
Study: 32648398

Group type: EXPERIMENTAL
Intervention: Cangguitanxue acupuncture combined with suspension exercise therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Suspension exercise therapy
Number of subjects: 100
Study: 36178534

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) therapy (100% oxygen, 240 kPa)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (21% oxygen, 240 kPa)
Number of subjects: 12
Study: 34496170

Group type: EXPERIMENTAL
Intervention: Origanum dubium essential oil
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Origanum vulgare subsp. hirtum essential oil
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lavandula angustifolia essential oil
Number of subjects: 34
Study: 34893432

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1.25× minimum alveolar concentration)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Propofol (1.25× minimum infusion rate)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Alfaxalone (1.25× minimum infusion rate)
Number of subjects: 8
Study: 32803010

Group type: EXPERIMENTAL
Intervention: Social capital measurement using Delaviz questionnaire
Number of subjects: 378
Study: 33181328

Group type: EXPERIMENTAL
Intervention: Favipiravir combined with inhaled interferon beta-1b
Number of subjects: 89

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 89
Study: 32160298

Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sevelamer carbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lanthanum carbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36200523

Group type: EXPERIMENTAL
Intervention: Diammonium glycyrrhizinate (DG) 150 mg three times a day combined with clarithromycin 250 mg once a day and isotretinoin 10 mg once every 2 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diammonium glycyrrhizinate (DG) 150 mg three times a day combined with clarithromycin 500 mg once a day and isotretinoin 10 mg once a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg once a day and isotretinoin 10 mg once a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg once a day and isotretinoin 10 mg once every 2 days combined with DG 150 mg three times a day
Number of subjects: 0
Study: 34460815

Group type: EXPERIMENTAL
Intervention: ZymoBIOMICS DNA Miniprep Kit
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: QIAamp PowerFecal Pro DNA Kit
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: QIAamp DNA Mini Kit
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IndiSpin Pathogen Kit
Number of subjects: 20
Study: 32324615

Group type: EXPERIMENTAL
Intervention: Concentrically focused resistance training
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Eccentrically focused resistance training
Number of subjects: 88

Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 88
Study: 36443579

Group type: EXPERIMENTAL
Intervention: Volar locking plate, 2 weeks casting + 3 weeks orthosis
Number of subjects: 100

Group type: COMPARATOR
Intervention: 5 weeks casting
Number of subjects: 100
Study: 34509276

Group type: EXPERIMENTAL
Intervention: Nutritionally balanced prefilled online grocery shopping cart (default cart)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nutrition education (NE)
Number of subjects: 38
Study: 32337917

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5%) and dexmedetomidine (0.5 μg/kg)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5%) plus magnesium sulfate
Number of subjects: 99

Group type: COMPARATOR
Intervention: Lidocaine (1.5%) adjusted to 35 cc with normal saline (Control)
Number of subjects: 99
Study: 35446726

Group type: EXPERIMENTAL
Intervention: MMR vaccine
Number of subjects: 0
Study: 33143064

Group type: EXPERIMENTAL
Intervention: Active Video Games (AVGs) intervention, played twice a week for eight weeks.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (usual activities).
Number of subjects: 87
Study: 34433763

Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 146

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 146
Study: 33764805

Group type: EXPERIMENTAL
Intervention: CC-486 (300 mg)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 32304218

Group type: EXPERIMENTAL
Intervention: Intensive induction followed by myeloablative chemotherapy and autologous hematopoietic cell rescue (AuHCR)
Number of subjects: 92
Study: 36919843

Group type: EXPERIMENTAL
Intervention: Pathogenic variant in a colorectal cancer gene
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Variants of Uncertain Significance (VUS)
Number of subjects: 1003
Study: 33135179

Group type: EXPERIMENTAL
Intervention: Intra-oral camera and/or social work consultation
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Both interventions (intra-oral camera and social work consultation)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 418
Study: 35357079

Group type: EXPERIMENTAL
Intervention: Low-dose Lomecel-B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose Lomecel-B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33378609

Group type: EXPERIMENTAL
Intervention: mRNA-1273 (100 µg)
Number of subjects: 30420

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30420
Study: 32815805

Group type: EXPERIMENTAL
Intervention: Locked plating followed by intraoperatively performed glenohumeral joint lavage (group L, n = 31)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Locked plating without the lavage (group NL, n = 31)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Locked plating followed by intraoperatively performed glenohumeral joint lavage (group L)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Locked plating without the lavage (group NL)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Overall complication rate
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Avascular necrosis in group L
Number of subjects: 86

Group type: COMPARATOR
Intervention: Avascular necrosis in group NL
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Secondary displacement in group L
Number of subjects: 86

Group type: COMPARATOR
Intervention: Secondary displacement in group NL
Number of subjects: 86
Study: 35205002

Group type: COMPARATOR
Intervention: Ketofol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lidoketofol
Number of subjects: 200
Study: 33692093

Group type: EXPERIMENTAL
Intervention: Index-beat approach
Number of subjects: 160

Group type: COMPARATOR
Intervention: 5 consecutive beats
Number of subjects: 160

Group type: COMPARATOR
Intervention: 10 consecutive beats
Number of subjects: 160

Group type: COMPARATOR
Intervention: 5-beat analysis
Number of subjects: 160

Group type: COMPARATOR
Intervention: 10-beat analysis
Number of subjects: 160
Study: 32784192

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 176
Study: 35844810

Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neostigmine 50 mcg/kg
Number of subjects: 30
Study: 32143278

Group type: EXPERIMENTAL
Intervention: Alkalizing diet (BASE)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Acidizing diet (ACID)
Number of subjects: 15
Study: 33917889

Group type: EXPERIMENTAL
Intervention: Early vocal contact (EVC) - mothers talk and sing to infants for 10 min three times per week for 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group - mothers spend the same amount of time next to the incubator and observe the infant's behaviour
Number of subjects: 80
Study: 32035551

Group type: EXPERIMENTAL
Intervention: Biological mesh reinforcement
Number of subjects: 790

Group type: COMPARATOR
Intervention: Standard closure with sutures alone (control)
Number of subjects: 790
Study: 35227959

Group type: EXPERIMENTAL
Intervention: Early norepinephrine initiation (within the first 3 hours)
Number of subjects: 2862

Group type: COMPARATOR
Intervention: Delayed norepinephrine initiation (after 3 hours)
Number of subjects: 2862

Group type: EXPERIMENTAL
Intervention: Early norepinephrine initiation
Number of subjects: 2862

Group type: COMPARATOR
Intervention: Delayed norepinephrine initiation
Number of subjects: 2862
Study: 34062053

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 0
Study: 36085237

Group type: EXPERIMENTAL
Intervention: Combined 2×/week aerobic training (AT) + 2×/week resistance training (RT)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 2×/week AT + 2×/week balance and tone (BAT)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 2×/week RT + 2×/week BAT
Number of subjects: 216

Group type: COMPARATOR
Intervention: 4×/week BAT (active control)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Health-related quality of life
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Physical function
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Actigraphy measures
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Questionnaires
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Falls
Number of subjects: 216
Study: 33063921

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 21
Study: 35650437

Group type: COMPARATOR
Intervention: Combination broadly neutralizing monoclonal antibodies (3BNC117 and 10-1074), administered up to 8 infusions over 24 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination broadly neutralizing monoclonal antibodies (3BNC117 and 10-1074) in antiretroviral-therapy-naive participants.
Number of subjects: 0
Study: 36388277

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (moderate-intensity, 3-5 times a week for 8 weeks)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 180

Group type: COMPARATOR
Intervention: Free activities (control group)
Number of subjects: 180
Study: 34106446

Group type: EXPERIMENTAL
Intervention: Short Physical Performance Battery (SPPB)
Number of subjects: 89
Study: 32658250

Group type: EXPERIMENTAL
Intervention: TAK-003 (tetravalent dengue vaccine candidate), 2 doses, administered 90 days apart (in part 1)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: TAK-003 (tetravalent dengue vaccine candidate)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 32867544

Group type: EXPERIMENTAL
Intervention: Hypnosis Group (Group H)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard Care Group (Group SC)
Number of subjects: 90
Study: 35886680

Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Walking Group (WG)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 67
Study: 34151824

Group type: EXPERIMENTAL
Intervention: CS+ group (1 mL AWB, 1 mL 20% dextrose, 0.4 mL 2% lidocaine, 0.1 mL (0.4 mg) dexamethasone palmitate)
Number of subjects: 140

Group type: COMPARATOR
Intervention: CS- group (same solution as CS+ but without dexamethasone palmitate)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 140
Study: 32881550

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy plus motivational interviewing
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (CBT)
Number of subjects: 85
Study: 34865226

Group type: EXPERIMENTAL
Intervention: Anterior VR-group (group 1) using VR-glasses for anterior tooth morphologies
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Posterior VR-group (group 2) using VR-glasses for posterior tooth morphologies
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional learning
Number of subjects: 82
Study: 32737096

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enoxaparin/warfarin
Number of subjects: 0
Study: 36224110

Group type: EXPERIMENTAL
Intervention: Dietary supplements (multivitamins, minerals, and omega-3 fatty acids)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 33989330

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Rural residence
Number of subjects: 494

Group type: COMPARATOR
Intervention: ≥ 6 months pre-ART duration
Number of subjects: 494

Group type: COMPARATOR
Intervention: Ambulatory or bedridden functional status at enrolment
Number of subjects: 494

Group type: COMPARATOR
Intervention: Did not take Cotrimoxazole preventive therapy (CPT) during follow-up
Number of subjects: 494
Study: 32961589

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS) protocol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional Care (CC) protocol
Number of subjects: 120
Study: 35499612

Group type: EXPERIMENTAL
Intervention: Prophylactic use of scopolamine butylbromide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32065499

Group type: EXPERIMENTAL
Intervention: Continence Product Patient Decision Aid (CP-PDA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 33168668

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 32463279

Group type: EXPERIMENTAL
Intervention: Menthol flavor
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Green apple flavor
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Menthol + green apple flavor
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IV nicotine (0.25 mg/70 kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IV nicotine (0.5 mg/70 kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 24
Study: 32188485

Group type: EXPERIMENTAL
Intervention: Continuous Kangaroo Mother Care (KMC) initiated as soon as possible after birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current recommendation of initiating continuous KMC after stabilization
Number of subjects: 0
Study: 36245436

Group type: EXPERIMENTAL
Intervention: 40 mg baclofen (oral) 1 h before study
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 32921155

Group type: EXPERIMENTAL
Intervention: Injection dexamethasone with oral glycerol (group I)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Injection dexamethasone alone (group II)
Number of subjects: 150
Study: 32679761

Group type: EXPERIMENTAL
Intervention: Low-caloric diet intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline concentration of three lysophospholipids (PC(22:4/0:0), PE(17:1/0:0), and PC(22:5/0:0))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical parameters and levels of circulating lysophospholipids and bile acids
Number of subjects: 0
Study: 35869939

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) with MTZ (400 mg) and AMX (500 mg) three times a day for 14 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) with placebo
Number of subjects: 30
Study: 33587831

Group type: EXPERIMENTAL
Intervention: Listening to Quran
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Listening to music
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 238
Study: 35262910

Group type: EXPERIMENTAL
Intervention: Caplacizumab treatment
Number of subjects: 11
Study: 35704062

Group type: EXPERIMENTAL
Intervention: Bridge-Enhanced ACL Restoration (BEAR)
Number of subjects: 65
Study: 32771461

Group type: EXPERIMENTAL
Intervention: Early outpatient treatment of COVID-19 with therapeutic approaches including reduction of reinoculation, combination antiviral therapy, immunomodulation, antiplatelet/antithrombotic therapy, and administration of oxygen, monitoring, and telemedicine.
Number of subjects: 0
Study: 32496886

Group type: EXPERIMENTAL
Intervention: SPLIT virtual keyboard
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lap posture
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Task duration
Number of subjects: 18
Study: 33053245

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Program
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Shock Wave Therapy associated with Aerobic Exercise Program
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (evaluations only)
Number of subjects: 45
Study: 32171367

Group type: EXPERIMENTAL
Intervention: Harti Hauora Tamariki tool (Harti tool)
Number of subjects: 0
Study: 36107632

Group type: EXPERIMENTAL
Intervention: FASTER-assisted ESD
Number of subjects: 4
Study: 33452108

Group type: EXPERIMENTAL
Intervention: HF‐rTMS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: iTBS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 60
Study: 32153208

Group type: EXPERIMENTAL
Intervention: Meditative Slow Breathing (MSB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isha Kriya (IK)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 40
Study: 36432471

Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 34320285

Group type: EXPERIMENTAL
Intervention: Anastrozole for 2 years (total of 7 years)
Number of subjects: 3484

Group type: COMPARATOR
Intervention: Anastrozole for 5 years (total of 10 years)
Number of subjects: 3484
Study: 34780032

Group type: EXPERIMENTAL
Intervention: Verbal instruction supplemented by teaching model
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Verbal instruction
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Verbal instruction supplemented by written instruction
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Verbal instruction supplemented by videotape
Number of subjects: 120
Study: 34052826

Group type: EXPERIMENTAL
Intervention: Weight support feedback cane gait training (WSFC group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional cane gait training (CC group)
Number of subjects: 30
Study: 32030923

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 2739

Group type: COMPARATOR
Intervention: Unvaccinated group
Number of subjects: 2739
Study: 34987147

Group type: EXPERIMENTAL
Intervention: Antibiotic administration (broad-spectrum antibiotics)
Number of subjects: 210

Group type: COMPARATOR
Intervention: No antibiotic administration (antibiotic-naïve)
Number of subjects: 210
Study: 34766811

Group type: EXPERIMENTAL
Intervention: Whole-school equity intervention within a school-wide PBIS framework
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (schools not receiving the intervention)
Number of subjects: 8
Study: 32600325

Group type: EXPERIMENTAL
Intervention: Fiber reinforced composite (FRC) retainers
Number of subjects: 52

Group type: COMPARATOR
Intervention: Multistranded stainless steel (MSW) retainers
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both types of retainers
Number of subjects: 52
Study: 34601602

Group type: EXPERIMENTAL
Intervention: Bilateral continuous pecto-intercostal fascial block (PIFB)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Saline (SAL group)
Number of subjects: 116
Study: 33306240

Group type: EXPERIMENTAL
Intervention: Machine-learning radiomics multilevel model
Number of subjects: 274
Study: 35715460

Group type: EXPERIMENTAL
Intervention: transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 19